XML 24 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Cash Flows - USD ($)
 9 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net increase (decrease) in net assets resulting from operations $ 1,923,639 $ 9,622,538 $ 7,340,108
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Net realized (gain) loss from investments 0 74,483 210,767
Net change in unrealized (appreciation) depreciation from investments 273,348 (246,004) (922,031)
Net (accretion of discounts) and amortization of premiums (165,398) (1,101,295) (810,554)
Purchase of investments (50,362,500) (29,943,975) (8,442,000)
PIK interest capitalized 0 (743,775) (115,725)
Proceeds from sales of investments and principal repayments 0 21,410,831 6,214,093
(Increase) Decrease in operating assets:      
Interest receivable (1,549,867) (1,827,250) (196,279)
Receivable for investment sold 0 (4,122,500) 0
Due from affiliates 0 (2,361,019) 0
Prepaid expenses and other assets 224,189 (133,953) (56,953)
Increase (Decrease) in operating liabilities:      
Income-based incentive fees payable 0 487,692 1,511,253
Management fee payable 170,965 501,241 86,156
Capital gains incentive fees payable 0 34,304 87,583
Professional fees payable 54,810 26,856 221,639
Transaction fees payable related to the Loan Portfolio Acquisition 0 2,233,861 711,264
Other payables 8,305 32,397 (19,841)
Due to affiliates (48) 905,129 (37)
Excise tax payable 80,566 78,054 (69,911)
Deferred income payable 0 37,752 0
Offering cost payable (264,581) 0 0
Organizational costs payable (34,168) 0 0
Net cash (used in) provided by operating activities (49,640,740) (5,034,633) 5,749,532
Cash flows from financing activities      
Proceeds from issuance of common stock 0 9,049,462 0
Offering costs paid 0 (274,728) 0
Distributions paid 0 (12,419,330) (8,263,217)
Net cash (used in) provided by financing activities 0 (3,644,596) (8,263,217)
Net (decrease) increase in cash and cash equivalents (49,640,740) (8,679,229) (2,513,685)
Cash and cash equivalents, beginning of period 84,766,060 32,611,635 35,125,320
Cash and cash equivalents, end of period 35,125,320 23,932,406 32,611,635
Supplemental disclosure of non-cash financing and investing activity      
Loans acquired for issuances of shares of common stock 0 210,571,663 0
Reinvestment of dividend distributions 0 812 2,318
Accrual for deferred financing costs (Note 2) 0 47,881 0
Accrual for deferred offering costs (Note 2) 0 49,998 0
Excise tax paid $ 0 $ 41,969 $ 80,566